Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Treatment of modifiable risk factors for foot ulceration in persons with diabetes: a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Glucose homeostasis in statin users-The LIFESTAT study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Oral insulin does not alter gut microbiota composition of NOD mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Kim Henriksen
  • Inger Byrjalsen
  • Per Qvist
  • Henning Beck-Nielsen
  • Gitte Hansen
  • Bente J Riis
  • Hans Perrild
  • Ole Lander Svendsen
  • Jeppe Gram
  • Morten A Karsdal
  • Claus Christiansen
  • BALLET Trial Investigators
Vis graf over relationer
Treatment of patients with perioxisome proliferator-activated receptor-γ full agonists are associated with weight gain, heart failure, peripheral oedema, and bone loss. However, the safety of partial perioxisome proliferator-activated receptor-γ agonists has not been established in a clinical trial. The BALaglitazone glucose Lowering Efficacy Trial aimed to establish the glucose-lowering effects and safety parameters of the perioxisome proliferator-activated receptor-γ partial agonist balaglitazone in diabetic patients on stable insulin therapy.
OriginalsprogEngelsk
TidsskriftDiabetes - Metabolism: Research and Reviews (Print Edition)
Vol/bind27
Udgave nummer4
Sider (fra-til)392-401
Antal sider10
ISSN1520-7552
DOI
StatusUdgivet - 2011

ID: 34796416